Chapter 1. Introduction (2025-2033)
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights) (2025-2033)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary (2025-2033)
3.1. Market Snapshot
Chapter 4. Market Variables and Scope (2025-2033)
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID-19 Impact on Contraceptive Drugs and Devices Market (2025-2033)
5.1. COVID-19 Landscape: Contraceptive Drugs and Devices Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends (2025-2033)
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape (2025-2033)
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Contraceptive Drugs and Devices Market, By Product (2025-2033)
8.1. Contraceptive Drugs and Devices Market Revenue and Volume, By Product, (2025-2033)
8.1.1 Contraceptive Drugs
8.1.1.1. Market Revenue and Volume Forecast (2025-2033)
8.1.2. Contraceptive Devices
8.1.2.1. Market Revenue and Volume Forecast (2025-2033)
Chapter 9. Global Contraceptive Drugs and Devices Market, By Distribution Channels Outlook (2025-2033)
9.1. Contraceptive Drugs and Devices Market Revenue and Volume, By Distribution Channels Outlook, (2025-2033)
9.1.1. Hospital Pharmacy
9.1.1.1. Market Revenue and Volume Forecast (2025-2033)
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Volume Forecast (2025-2033)
9.1.3. Clinics
9.1.3.1. Market Revenue and Volume Forecast (2025-2033)
9.1.4. Online Channels
9.1.4.1. Market Revenue and Volume Forecast (2025-2033)
9.1.5. Public Channels & NGOs
9.1.5.1. Market Revenue and Volume Forecast (2025-2033)
9.1.6. Other
9.1.6.1. Market Revenue and Volume Forecast (2025-2033)
Chapter 10. Global Contraceptive Drugs and Devices Market, Regional Estimates and Trend Forecast (2025-2033)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.1.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.1.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.1.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.2.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.2.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.2.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.2.5.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.2.6.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.3.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.3.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.3.5.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.3.6.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.4.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.4.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.4.5.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.4.6.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.5.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.5.3.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product (2025-2033)
10.5.4.2. Market Revenue and Volume Forecast, By Distribution Channels Outlook (2025-2033)
Chapter 11. Company Profiles (2025-2033)
11.1. Abbvie, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Afaxys, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Agile Therapeutics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. China Resources (Holdings) Co., Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Church & Dwight Co., Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cupid Limited
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Helm AG
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Johnson & Johnson Services, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Organon Group of Companies
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Pfizer Inc.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Veru, Inc.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Viatris Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
Chapter 12. Research Methodology (2025-2033)
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix (2025-2033)
13.1. About Us
13.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます
